During the past decade, Tokyo Medical Uni. Hospital; Breast Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Medical Uni. Hospital; Breast Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Medical Uni. Hospital; Breast Oncology" are "Breast Cancer" (3 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Tokyo Medical Uni. Hospital; Breast Oncology" in a lesser frequency.

Most popular intervention types in "Tokyo Medical Uni. Hospital; Breast Oncology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Pertuzumab" (3 trials), "Trastuzumab" (3 trials), "5-Fluorouracil" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Medical Uni. Hospital; Breast Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Medical Uni. Hospital; Breast Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tokyo Medical Uni. Hospital; Breast Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Medical Uni. Hospital; Breast Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".